Diversifying Genomic Research & Clinical Trials
We believe diversifying genomic research and clinical trials to include more people of color increases knowledge about health issues and makes a difference in personalized healthcare for all.
WHAT WE DO
We help biopharmaceutical companies and contract research organizations achieve the most representative research sample by expanding their genomic studies and clinical trials to include diverse ethnic groups.
Our Enhanced Diversity in Clinical Trials (e-DICT) is a HIPPA compliant platform that utilizes artificial intelligence, machine learning, and predictive analytics to automate the identification, education, engagement, and retention of willing & diverse clinical trial participants. The result is a ready supply of willing, educated, and diverse participants for genomic research and clinical trials. Our unique system helps decrease the overall cost of drug development and increase the speed of FDA approval.
Where We Call Home
Opened in 2008, HudsonAlpha Institute for Biotechnology has become a international leader in genomics research and biotech education. HudsonAlpha leverages the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The state-of-the-art facilities bring together scientific researchers with entrepreneurs and educators. and fosters more than 40 diverse biotech companies on campus.
To learn more about HudsonAlpha, visit hudsonalpha.org
It Starts with a Passion
DELMONIZE SMITH, PHD
Founder & CEO
Dr. Delmonize “Del” Smith has extensive management and leadership experience in healthcare, IT, education, and government. In addition to being a military veteran, Del's career includes work as an analyst at McKesson, Memorial Hermann Health Systems, and U.S. Oncology. He has successfully launched and sold two tech-related companies. Del earned a Bachelor of Business Administration from Faulkner University, a Master of Science in Management from Troy University, and a Ph.D. in Management from the University of Alabama.
ACCLINATE GENETICS TEAMS WITH GOVERNOR'S OFFICE OF MINORITY AFFAIRS
Oct. 28, 2019
ACCLINATE SEEKS TO EDUCATE MINORITIES ON IMPORTANCE OF CLINICAL TRIALS
Sept. 5, 2019
MANAGEMENT SYSTEM AIMS TO ENHANCE DIVERSITY IN US CLINICAL TRIALS
August 12, 2019
ALABAMA-BASED GENETIC RESEARCH FIRM AT FOREFRONT TO DRIVE DIVERSE CLINICAL TRIAL PARTICIPATION
August 10, 2019
ACCLINATE GENETICS WORKS TO FIGHT HEALTH DISPARITIES
August 28, 2019
HUNTSVILLE COMPANY ON A MISSION TO TRANSFORM THE STATUS QUO OF CLINICAL RESEARCH
August 12, 2019
ACCLINATE GENETICS WANTS MINORITIES REPRESENTED IN CLINICAL RESEARCH
August 9, 2019